Sarepta Therapeutics Inc (SRPT)
Return on assets (ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -535,977 | -703,488 | -418,780 | -554,128 | -715,075 |
| Total assets | US$ in thousands | 3,264,580 | 3,128,370 | 3,147,970 | 2,984,720 | 1,822,820 |
| ROA | -16.42% | -22.49% | -13.30% | -18.57% | -39.23% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $-535,977K ÷ $3,264,580K
= -16.42%
Sarepta Therapeutics Inc's return on assets (ROA) has shown fluctuating performance over the past five years. The ROA was -16.42% in 2023, -22.49% in 2022, -13.30% in 2021, -18.57% in 2020, and -39.23% in 2019.
These negative ROA figures indicate that the company is not efficiently utilizing its assets to generate profits. The decreasing trend from 2019 to 2021 shows a deterioration in the company's ability to generate earnings relative to its asset base. However, the slight improvement in ROA in 2023 compared to 2022 suggests that the company may be taking steps to enhance asset utilization.
Overall, Sarepta Therapeutics Inc's ROA performance indicates a need for the company to focus on enhancing operational efficiency and asset management to improve profitability and investor returns.
Peer comparison
Dec 31, 2023